###begin article-title 0
Sox6 regulation of cardiac myocyte development
###end article-title 0
###begin p 1
###xml 95 115 95 115 <email xmlns:xlink="http://www.w3.org/1999/xlink">mhb@peds.arizona.edu</email>
To whom correspondence should be addressed. Tel: +1 520 626 3305; Fax: +1 520 626 7407; Email: mhb@peds.arizona.edu
###end p 1
###begin p 2
###xml 18 19 18 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 19 23 19 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 24 25 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 25 29 25 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 232 236 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 267 275 267 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 331 335 331 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 494 530 494 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Proline-rich transcript of the brain</italic>
###xml 632 636 632 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 962 964 958 960 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 995 996 991 992 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 994 996 990 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 1102 1106 1098 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 1110 1114 1106 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 1172 1174 1168 1170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1180 1182 1172 1174 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 1204 1208 1196 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 1213 1217 1205 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 1261 1263 1253 1255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1269 1271 1257 1259 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 1342 1344 1330 1332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1350 1352 1334 1336 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 1373 1380 1357 1364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1406 1407 1390 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1407 1411 1391 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 1407 1411 1391 1395 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 1412 1413 1396 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1413 1417 1397 1401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 1413 1417 1397 1401 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 1586 1588 1570 1572 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
###xml 448 453 <span type="species:ncbi:4932">yeast</span>
###xml 1425 1429 <span type="species:ncbi:10090">mice</span>
A mouse mutation (p100H/p100H) has been identified that is associated with cardioskeletal myopathy, heart block, delayed growth and early postnatal death. The gene that is disrupted in this mutation encodes the transcription factor Sox6. P19CL6 cells were used as an in vitro cardiomyocyte differentiation system and revealed that Sox6 is expressed exclusively when the cells are committed to differentiate to beating cardiac myocytes. We used the yeast two-hybrid system to identify the Prtb (Proline-rich transcript of the brain) protein as a Sox6 interactor, and subsequently confirmed the interaction by co-immunoprecipitation. Prtb expression in P19CL6 cells increased with differentiation to beating cardiomyocytes. Using the P19CL6 cells stably transfected with noggin, an antagonist of BMP (Bone Morphogenic Protein), we found that BMP expression is required for Sox6 expression in cardiomyocyte differentiation. Surprisingly, the expression of the alpha1c-subunit gene of the L-type Ca2+ channel decreased in P19CL6 cells as they differentiated to beating cardiac cells. Ectopic expression of Sox6 or Prtb alone in P19CL6 cells caused down-regulation of L-type Ca2+ alpha1c expression, but when Sox6 and Prtb were co-transfected to the cells, L-type Ca2+ alpha1c remained at basal levels. A similar relationship of Sox6 and L-type Ca2+ alpha1c expression was seen in vivo (comparing wild-type and p100H/p100H mutant mice). Thus, Sox6 is within the BMP pathway in cardiac differentiation, interacts with Prtb and may play a critical role in the regulation of a cardiac L-type Ca2+ channel.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c1">1</xref>
In distinct muscle cell lineages, individual muscle-specific genes exhibit unique temporal-spatial patterns of expression. Regulatory programs for myocyte transcription result from developmental cues and positional information that are mediated by specific transcription factors. The transcriptional expression pattern of muscle-specific genes is ultimately dependent on combinatorial interactions among the transcription factors that bind different regulatory proteins (1).
###end p 4
###begin p 5
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox</italic>
###xml 9 10 9 10 <underline xmlns:xlink="http://www.w3.org/1999/xlink">S</underline>
###xml 9 12 9 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><underline>S</underline>ry</italic>
###xml 26 28 26 28 <underline xmlns:xlink="http://www.w3.org/1999/xlink">ox</underline>
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c2">2</xref>
###xml 189 193 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c3">3</xref>
###xml 275 276 275 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c4">4</xref>
###xml 279 283 279 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 348 349 348 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c5">5</xref>
###xml 500 501 500 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c5">5</xref>
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c4">4</xref>
###xml 522 523 522 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c6">6</xref>
###xml 524 525 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c8">8</xref>
###xml 577 578 577 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c3">3</xref>
###xml 603 607 603 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 623 624 623 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 624 628 624 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 624 628 624 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 686 687 686 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c3">3</xref>
###xml 706 707 706 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 707 711 707 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 707 711 707 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 740 741 740 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 741 745 741 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 741 745 741 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 895 896 895 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c9">9</xref>
###xml 1064 1065 1064 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c3">3</xref>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c10">10</xref>
###xml 1388 1392 1388 1392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 1490 1491 1490 1491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c3">3</xref>
###xml 1492 1494 1492 1494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c10">10</xref>
###xml 266 271 <span type="species:ncbi:10090">mouse</span>
###xml 321 326 <span type="species:ncbi:10090">mouse</span>
###xml 581 585 <span type="species:ncbi:10090">Mice</span>
###xml 869 874 <span type="species:ncbi:9606">human</span>
###xml 1110 1115 <span type="species:ncbi:9606">human</span>
###xml 1175 1180 <span type="species:ncbi:9606">human</span>
###xml 1229 1234 <span type="species:ncbi:10090">mouse</span>
###xml 1365 1370 <span type="species:ncbi:9606">human</span>
###xml 1382 1387 <span type="species:ncbi:10090">mouse</span>
The Sox (Sry related HMG box) gene family encodes an important group of transcription factors that are key regulators of embryonic development and cell fate determination (2). Mutations of Sox6, a member of this family, are associated with neonatal lethality in the mouse (3,4). Sox6 was initially isolated from an adult mouse testis cDNA library (5), but its functional significance in this tissue is unknown. Sox6 has been suggested to play a role in the development of the central nervous system (5), chondrogenesis (4,6-8) and cardiac and skeletal muscle cell maintenance (3). Mice homozygous for a Sox6 null mutation, p100H, show delayed growth and die within 2 weeks after birth (3). Analysis of the p100H phenotype revealed that the p100H mutant develops myopathy and arterioventricular (AV) heart block, a cardiac conduction defect associated with lethality in human cardiac myopathies (9). Thus, among its diverse functions, the Sox6 protein is likely to be involved in maintaining the normal physiological function of muscle tissue, including the heart (3). We have recently cloned and sequenced the human SOX6 cDNA, isolated from a myoblast cDNA library (10). The human SOX6 protein shows 94.3% amino acid identity to mouse Sox6 throughout the gene, and 100% identity in the critical HMG box and coiled-coil domains. Northern blot analysis revealed that human SOX6, like mouse Sox6, is expressed in a wide variety of tissues, and is most abundantly expressed in skeletal muscle (3,10).
###end p 5
###begin p 6
###xml 253 258 <span type="species:ncbi:4932">yeast</span>
The muscle cell-specific effects of the Sox6 protein may be achieved by its interactions with other transcription factors. To identify Sox6 interactors in muscle cells and elucidate how the Sox6 protein achieves such remarkable cell type specificity, a yeast two-hybrid screening was performed. This identified the Prtb (Proline-rich transcript of the brain) protein as an interactor of the Sox6 protein.
###end p 6
###begin p 7
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c11">11</xref>
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 397 401 397 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c12">12</xref>
To understand the role of Sox6 in cardiac muscle development, we utilized P19CL6, a cell line that differentiates exclusively to beating cardiomyocytes in the presence of DMSO (11). Sox6 is not expressed in untreated P19CL6 cells, but is up-regulated following DMSO exposure, reaching maximum levels when the cells have fully differentiated into beating cardiomyocytes. In addition, we found that Sox6 is downstream of the BMP (Bone Morphogenetic Protein) pathway in the cardiac system, using P19CL6noggin, a P19CL6 cell line stably transfected with noggin that antagonizes the BMP pathway (12).
###end p 7
###begin p 8
###xml 105 107 105 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 121 123 117 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 182 184 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c13">13</xref>
###xml 233 235 229 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 249 251 241 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 366 370 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 389 390 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 390 394 382 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 390 394 382 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 395 396 387 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 396 400 388 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 396 400 388 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 403 404 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c3">3</xref>
###xml 511 519 491 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 615 617 595 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 631 633 607 609 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 648 652 624 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 671 675 647 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
To assess the effect of Sox6 in cardiac differentiation, we characterized the expression of the L-type Ca2+ channel alpha1c gene, encoding a subunit normally expressed in the heart (13). We found that the mRNA levels of the L-type Ca2+ channel alpha1c gene decreased when the P19L6 cells terminally differentiate or when they are transfected with Sox6. Moreover, in Sox6 null mutant mice (p100H/p100H) (3), the expression level of this calcium channel gene is approximately1.5-fold higher, correlating with the in vitro analysis. The Sox6 interactor, Prtb, also down-regulated the expression levels of the L-type Ca2+ channel alpha1c gene, whereas Prtb co-expressed with Sox6 did not.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Plasmid construction
###end title 10
###begin p 11
###xml 729 733 729 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 738 742 738 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 164 169 <span type="species:ncbi:4932">yeast</span>
###xml 325 330 <span type="species:ncbi:10090">mouse</span>
###xml 723 728 <span type="species:ncbi:10090">mouse</span>
###xml 853 856 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
DNA fragments for plasmid constructs were generated by PCR or RT-PCR and confirmed by sequence analysis. To construct the plasmid pGBKT7 (Clontech) as bait for the yeast two-hybrid screen and for the co-immunoprecipitation (Co-IP), an amplified PCR fragment encoding amino acids 139-304 (including the coiled-coil domain) of mouse Sox6 (GenBank accession no. U32614) was cloned in-frame into EcoRI-SalI sites. To generate the plasmid pGADT7 (Clontech) for the Co-IP, the amplified PCR fragment encoding the first 108 amino acids of the Prtb gene (GenBank accession no. AF085348), and RT-PCR of the entire gene (168 amino acids), were cloned in-frame into EcoRI-XhoI sites. For transient transfection, complete cDNAs of the mouse Sox6 and Prtb genes were cloned into EcoRI, and EcoRI-XhoI, respectively, to pCDNA3.1/Zeo vector (Invitrogen) driven by the CMV promoter.
###end p 11
###begin title 12
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast two-hybrid screening
###end title 12
###begin p 13
###xml 479 480 479 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 547 548 547 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 603 604 603 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 161 166 <span type="species:ncbi:10090">mouse</span>
###xml 245 250 <span type="species:ncbi:4932">yeast</span>
###xml 335 340 <span type="species:ncbi:4932">yeast</span>
The MATCHMAKER two-hybrid system 3 (Clontech) was used according to the supplier's protocol with the Sox6 bait plasmid, detailed above. The screened library was mouse 11 day embryo MATCHMAKER cDNA (Clontech) that was pre-transformed to the Y187 yeast strain. The two-hybrid screening of the pre-transformed library was accomplished by yeast mating using the AH109 strain containing the bait plasmid. The screening was preformed for growth on minimal medium lacking histidine (His-) and in the presence of 2.5 mM 3-amino-1,2,4-triazole. Of 2.3 x 106 cDNAs, approximately 300 positive colonies grew on His-. To exclude false positive clones, the 300 colonies were replicated to high stringency plates, with simultaneous selection for three reporter genes (lacking histidine and adenine and containing X-alpha-Gal as substrate that employs blue/white screening directly on the plate). Approximately 200 of these clones grew under high stringency. These were sequenced and evaluated by BLAST search for being in frame with the activation domain, for the potential as a transcription factor and for expression in the developing heart. Of these, one, partially encoding Prtb, was selected for further analysis.
###end p 13
###begin title 14
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
In vitro protein-protein interaction assay
###end title 14
###begin p 15
###xml 86 94 86 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 435 443 435 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 193 198 <span type="species:ncbi:10090">mouse</span>
###xml 282 287 <span type="species:ncbi:4932">yeast</span>
To confirm true protein interactions, we used the MATCHMAKER Co-IP kit (Clontech) for in vitro Co-IP, according to the supplier's protocol. The Co-IP contains two vectors: pGBKT7 (includes the mouse Sox6 coiled-coil domain), and pGADT7 (includes a library protein isolated from the yeast two-hybrid screening). These vectors contain a T7 RNA polymerase promoter and either a c-Myc or HA epitope tag, so they can be used directly in an in vitro transcription/translation reaction.
###end p 15
###begin title 16
RNA isolation and northern blot analysis
###end title 16
###begin p 17
###xml 494 498 490 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 608 612 604 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 721 725 717 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox9</italic>
###xml 847 848 843 844 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 846 848 842 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 853 855 845 847 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 1027 1029 1019 1021 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1191 1193 1183 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c14">14</xref>
###xml 1443 1447 1423 1427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 510 515 <span type="species:ncbi:10090">mouse</span>
###xml 624 629 <span type="species:ncbi:10090">mouse</span>
###xml 737 742 <span type="species:ncbi:10090">mouse</span>
###xml 867 872 <span type="species:ncbi:10090">mouse</span>
###xml 1325 1330 <span type="species:ncbi:9606">Human</span>
###xml 1335 1340 <span type="species:ncbi:10090">mouse</span>
###xml 1437 1442 <span type="species:ncbi:10090">mouse</span>
At varying times and treatments, cells were harvested for total RNA isolation using the UltraSpec RNA Isolation kit (Biotecx). For northern blot hybridization, equal amounts of total RNA (10 microg/lane) were subjected to electrophoresis on a 1.2% agarose gel in the presence of 5.5% formaldehyde and transferred by the alkaline method to a nylon membrane (Hybond N+; Amersham). The membranes were hybridized with distinct cDNA probes obtained by PCR or RT-PCR and confirmed by sequencing. The Sox6 probe is a mouse cDNA fragment of 575 bp including nucleotides 1353-1927 (GenBank accession no. U32614). The Prtb probe is a mouse cDNA fragment of 562 bp including nucleotides 15-576 (GenBank accession no. AF085348). The Sox9 probe is a mouse cDNA fragment of 278 bp including nucleotides 1049-1326 (GenBank accession no. BC034264). The L-type Ca2+alpha1c probes are mouse cDNA fragments of 548 and 540 bp including nucleotides 6294-6841 and 3072-3611, respectively (GenBank accession no. NM_009781). Probes were labeled with [32P]dCTP, by random primer labeling (RediprimeII; Amersham Pharmacia Biotech). The hybridization was performed in phosphate buffered 7% SDS hybridization solution (14). Blots were washed with 0.2x SSC, 1% SDS at 60degreesC prior to exposure to X-ray film (Kodak) at -80degreesC from 3 h to 6 days. Human and mouse multiple tissue northern filters were purchased from Clontech. The filters were hybridized with mouse Prtb cDNA nucleotides 15-576 (GenBank accession no. AF085348) following the manufacturer's protocols and exposed to X-ray film (Kodak) at -80degreesC for 19 h.
###end p 17
###begin title 18
Cell culture and differentiation
###end title 18
###begin p 19
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c11">11</xref>
###xml 205 206 205 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
P19CL6 and P19CL6noggin cell lines were cultured as described previously (11). To stimulate differentiation under adherent conditions, the P19CL6 and P19CL6noggin cells were plated at a density of 3.7 x 105 cells in a 60 mm tissue culture dish with medium including 1% DMSO. The medium was changed every 2 days. The P19CL6 cells started to beat after 11 days, and virtually all of the cells on the plate were beating after 14 days. Days of differentiation were numbered consecutively (i.e. day 0, no DMSO treatment; day 1, 24 h after DMSO added).
###end p 19
###begin title 20
Transient transfection assay
###end title 20
###begin p 21
###xml 396 397 390 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 461 465 451 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 469 473 459 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 958 959 935 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 309 312 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Transient transfections were performed in a 6-well dish using FuGENE6 reagent (Roche), according to the manufacturer's protocol. Bluescript II SK(-) plasmid was used as a control. To evaluate transfection efficiency, cells were co-transfected with a reporter vector containing the beta-gal gene driven by the CMV promoter (pCMV SPORT-betagal; Invitrogen). In each well of a 6-well plate, 3.5 x 105 cells were transfected with 1 microg of pCDNA3.1/Zeo harboring Sox6 or Prtb or both plasmids, and 0.5 microg of pCMV SPORT-betagal. Cells were harvested after 24 h post-transfection for RNA for northern blot analysis (as described above). The band intensities were determined with Quantity One software (GS-700 densitometer; Bio-Rad, Hercules, CA). Also at this point protein extracts were used for the beta-gal assay using the beta galactosidase enzyme assay kit (Promega). The experiment was repeated three times, and the statistical analysis was done using t-test.
###end p 21
###begin title 22
###xml 28 30 28 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 36 38 32 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
RT-PCR analysis of L-type Ca2+ alpha1c gene
###end title 22
###begin p 23
###xml 83 84 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 84 88 84 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 89 90 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 90 94 90 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 140 145 140 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12&#8211;18</sub>
###xml 219 221 219 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+2</sup>
###xml 227 229 223 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 562 567 <span type="species:ncbi:10090">mouse</span>
Total RNA from embryonic day 18.5 heart was isolated from littermate wild-type and p100H/p100H mutant mice. One microgram of RNA, Oligo (dT)12-18 primer and reverse transcriptase were used for cDNA production. L-type Ca+2 alpha1c cDNA analysis was performed by PCR amplification of a fragment of 548 bp using the primers: MHB1401, 5'-TATCAGAGTGACAGCAGGGGCAAC-3'; and MHB1402, 5'-AGAGAGGCAGAGCGAAGGAAAC-3'. PCRs were carried out with several dilutions of cDNAs and/or over a range of amplifying cycles to insure a linear range of amplification. A fragment of the mouse GPDH gene was amplified as internal control. Amplified products were electrophoresed on a 2% agarose gel, visualized under UV light and analyzed using a densitometer (Gel Doc 1000; Bio-Rad).
###end p 23
###begin title 24
RESULTS
###end title 24
###begin title 25
Screening for a candidate protein that interacts with Sox6
###end title 25
###begin p 26
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c6">6</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c10">10</xref>
###xml 488 492 488 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c3">3</xref>
###xml 698 702 698 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 769 771 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c15">15</xref>
###xml 796 800 796 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 890 897 890 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1067 1068 1067 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f1">1</xref>
###xml 1274 1282 1274 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 61 66 <span type="species:ncbi:4932">yeast</span>
###xml 163 168 <span type="species:ncbi:10090">mouse</span>
###xml 289 294 <span type="species:ncbi:10090">mouse</span>
###xml 299 304 <span type="species:ncbi:9606">human</span>
###xml 454 459 <span type="species:ncbi:10090">mouse</span>
###xml 872 877 <span type="species:ncbi:4932">yeast</span>
###xml 1609 1614 <span type="species:ncbi:4932">yeast</span>
To identify factors that interact with Sox6, we employed the yeast two-hybrid system. As bait, we used the coiled-coil domain including amino acids 139-304 of the mouse Sox6 protein. The leucine zipper motif and the Q-box create a coiled-coil domain (6) that is 100% conserved between the mouse and human SOX6, and has a 91% identity to L-Sox5 (10). This domain mediates homodimerization and heterodimerization. We screened a cDNA library from an 11-day mouse embryo, at a stage when the Sox6 gene is already expressed (3). One cDNA clone was selected for detailed analysis based on numerous criteria (see Materials and Methods). A BLAST search revealed that this clone contained two-thirds of the Prtb gene, including 108 amino acids (of 168 total) at the N-terminal (15). The full size cDNA of Prtb was subsequently isolated by RT-PCR. Although the two-hybrid system in yeast provides an in vivo analysis, it does not necessarily demonstrate direct interaction between these two proteins. To verify protein-protein interaction, we applied the Co-IP technique (Fig. 1). A c-Myc epitope tag was attached to the Sox6 bait, and an HA epitope tag was attached to both the isolated Prtb fragment (108 amino acids) and the full-length protein. The tagged proteins were expressed in vitro and non-denatured proteins and complexes were precipitated by anti-Myc or anti-HA. The proteins and complexes were then denatured and resolved by PAGE, verifying the interaction between the Sox6 and Prtb proteins. Both the 108 amino acid Prtb peptide and the full-length protein were co-precipitated with Sox6, confirming the yeast two-hybrid system results (data not shown).
###end p 26
###begin p 27
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c16">16</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c17">17</xref>
###xml 248 252 248 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 376 380 376 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 464 468 464 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 511 512 511 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f2">2</xref>
###xml 553 557 553 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 666 667 666 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c3">3</xref>
###xml 668 670 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c10">10</xref>
###xml 232 237 <span type="species:ncbi:9606">human</span>
###xml 242 247 <span type="species:ncbi:10090">mouse</span>
###xml 472 477 <span type="species:ncbi:9606">human</span>
###xml 485 490 <span type="species:ncbi:10090">mouse</span>
The Prtb protein has no known function. An analysis using the PROSITE motif search showed a possible 'paired box' domain (16) that may function in sequence-specific DNA recognition (17). There is a 92% sequence identity between the human and mouse Prtb genes. This high conservation between the two species may suggest a shared, and perhaps crucial, function of this protein. Prtb is expressed in various levels in a variety of tissues. The expression patterns of Prtb in human and in mouse are shown in Figure 2A and B, respectively. In both organisms Prtb is expressed at high levels in the heart, and at lower levels in skeletal muscle (when compared with Sox6) (3,10).
###end p 27
###begin title 28
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
Sox6 and Prtb expression during differentiation of P19CL6 cells and P19CL6noggin cells
###end title 28
###begin p 29
###xml 45 53 45 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c11">11</xref>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c18">18</xref>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c19">19</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c20">20</xref>
###xml 497 502 497 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c12">12</xref>
###xml 993 997 993 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 1048 1049 1048 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f3">3</xref>
###xml 1087 1088 1087 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f4">4</xref>
###xml 1091 1095 1091 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 1218 1219 1218 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f3">3</xref>
###xml 1406 1410 1406 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 1451 1455 1451 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 1506 1510 1506 1510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 1568 1569 1568 1569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f3">3</xref>
###xml 1598 1602 1598 1602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 1703 1707 1703 1707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 1780 1781 1780 1781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f3">3</xref>
###xml 1889 1893 1889 1893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 106 112 <span type="species:ncbi:10090">murine</span>
Cardiomyocyte differentiation can be studied in vitro using P19CL6 cells (11), a clonal derivative of P19 murine embryonal carcinoma cells (18). Unlike the parental P19 cells, this subline efficiently differentiates into beating cardiomyocytes under adherent conditions when treated with DMSO. This cell line expresses BMPs that have been shown to play a pivotal role in the induction of the cardiac cell lineage (19,20). To further investigate the functions of BMP in cardiac development, Monzen et al. (12) established a variant P19CL6 cell line, P19CL6noggin, that constitutively over-expresses noggin, an antagonist of BMP. Because of the continual presence of noggin in P19CL6noggin cells, myogenic induction is suppressed and neither cardiac transcription factors nor contractile protein genes are expressed. To understand where in the cardiomyocyte developmental pathway Sox6 and Prtb may be acting, we used P19CL6 and P19CL6noggin to analyze the expression of these genes. The mRNA of Sox6 is only detected when the cells are beating (Fig. 3) or committed to differentiate (Fig. 4). Sox6 mRNA was not detected in untreated or DMSO treated P19CL6noggin cells that do not differentiate into cardiomyocytes (Fig. 3). These results indicate that the expression of Sox6 in P19CL6 is associated with the initiation of the cardiomyogenic program and not with the DMSO treatment itself. In contrast to the Sox6 expression in P19CL6, the expression of Prtb is less affected by the presence of noggin, since Prtb is expressed in both P19CL6 and P19CL6noggin cells (Fig. 3). The highest expression of Prtb was observed when the P19CL6 cells are beating. In P19CL6noggin cells, DMSO treatment increased the Prtb mRNA level, but not to the level observed in beating P19CL6 cells (Fig. 3). It is, therefore, possible that DMSO treatment itself may have a partial effect on the expression of the Prtb gene.
###end p 29
###begin p 30
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 133 137 133 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox9</italic>
###xml 222 226 222 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c21">21</xref>
###xml 269 273 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f4">4</xref>
###xml 398 402 398 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f4">4</xref>
###xml 477 481 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox9</italic>
###xml 600 601 600 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f4">4</xref>
The temporal expression of Sox6 and Prtb in DMSO-treated P19CL6 cells was also analyzed by northern hybridization. The expression of Sox9 was also analyzed, because Sox9 has been shown to be required for the expression of Sox6 in chondrogenesis (21). The expression of Sox6 was faintly detectable at day 6, with highest expression on day 11 (Fig. 4), the first day that we could see beating cells. Prtb was faintly detected on day 0, with highest expression on day 6 (Fig. 4). Sox9 expression did not show any significant changes as DMSO-treated P19CL6 cells differentiated into cardiomyocytes (Fig. 4).
###end p 30
###begin title 31
###xml 23 25 23 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 31 33 27 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
Regulation of L-type Ca2+ alpha1c in the P19CL6 cell line
###end title 31
###begin p 32
###xml 3 4 3 4 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 2 4 2 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c22">22</xref>
###xml 153 154 153 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 152 154 152 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 319 320 319 320 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 318 320 318 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 356 357 352 353 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 364 365 356 357 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 432 433 413 414 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 512 514 489 491 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 600 602 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c23">23</xref>
###xml 619 620 596 597 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 618 620 595 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 672 674 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c24">24</xref>
###xml 701 702 678 679 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 700 702 677 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 708 710 681 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 814 815 787 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f5">5</xref>
###xml 851 852 824 825 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 850 852 823 825 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 858 860 827 829 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
Ca2+ channels play a crucial role in maintaining muscle contraction in response to depolarization of the plasma membrane (22). At least five types of Ca2+ channels have been identified and characterized. The L-type channel is the predominant type in heart and vascular tissues. There are four subunits of the L-type Ca2+ channel present in the heart: alpha1, alpha2, delta and beta, and there are also distinct isoforms of the alpha1 subunit, each with a unique gene product present in various tissues. The alpha1c subunit is expressed in cardiac and vascular smooth muscle, as well as in the brain (23). The L-type Ca2+ channel is critical for cardiomyocyte contraction (24). Expression of L-type Ca2+ alpha1c in P19CL6 cells is dramatically down-regulated following DMSO induction to beating cardiac cells (Fig. 5). However, expression of L-type Ca2+ alpha1c in P19CL6noggin cells was the same as in P19CL6 cells (with and without DMSO, data not shown).
###end p 32
###begin p 33
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 120 121 120 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 119 121 119 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 127 129 123 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 208 209 204 205 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 207 209 203 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 215 217 207 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 327 329 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c25">25</xref>
###xml 521 522 513 514 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 520 522 512 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 528 530 516 518 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 194 197 <span type="species:ncbi:10116">rat</span>
###xml 539 544 <span type="species:ncbi:10090">mouse</span>
It is possible that the expression of Sox6 and Prtb may have a significant effect on the transcription of the L-type Ca2+ alpha1c gene, as it has been reported that the upstream sequence of the rat L-type Ca2+ alpha1c gene contains a repressor sequence between -1000 and -2000 bp relative to the transcription initiation site (25). This region contains seven consensus binding sites for Sox proteins (the potential binding sites of Prtb are unknown). We analyzed 4.1 kb of the regulatory region upstream of the L-type Ca2+ alpha1c cDNA in mouse (accession no. NM_009781), and detected eight perfect consensus binding sites for Sox proteins within a 1650 bp fragment located 1270 bp upstream of the published cDNA (data not shown).
###end p 33
###begin p 34
###xml 74 75 74 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 73 75 73 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 81 83 77 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 147 148 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f6">6</xref>
###xml 166 170 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 175 179 171 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 295 296 291 292 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 294 296 290 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 302 304 294 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 455 456 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f6">6</xref>
###xml 496 500 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 505 509 494 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 553 554 542 543 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 552 554 541 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 560 562 545 547 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 569 570 554 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f6">6</xref>
###xml 598 602 583 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 627 631 612 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 661 662 646 647 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 660 662 645 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 668 670 649 651 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 235 238 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 436 439 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
To examine the direct effect of Sox6 on the expression level of L-type Ca2+ alpha1c, we performed transient transfections using P19CL6 cells (Fig. 6A). We introduced Sox6 and Prtb cDNA individually, or together, under the control of a CMV promoter, and analyzed the mRNA levels of the L-type Ca2+ alpha1c gene by northern blot analysis. To determine the transfection efficiency, we co-transfected the cells with beta-gal, driven by the CMV promoter (Fig. 6B). When transfected individually, both Sox6 and Prtb down-regulated the expression of L-type Ca2+ alpha1c (Fig. 6A and B). In contrast, when Prtb was co-transfected with Sox6, the expression of L-type Ca2+ alpha1c remained the same as the control level.
###end p 34
###begin p 35
###xml 48 49 48 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 47 49 47 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 55 57 51 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 185 187 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c26">26</xref>
###xml 312 313 296 297 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 311 313 295 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 319 321 299 301 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 638 639 606 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f5">5</xref>
###xml 644 645 612 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f6">6</xref>
It has been shown previously that the L-type Ca2+ alpha1c transcript undergoes alternative splicing and produces three different transcripts in heart, approximately15.5, 8.9 and 20 kb (26). To confirm that we were assaying gene expression and not alternative splicing, we used two different probes for L-type Ca2+ alpha1c (see Materials and Methods). One probe encompassed the 5' region of the cDNA spanning three exons and the other probe encompassed the 3' region of the cDNA spanning four exons. We detected only the approximately15.5 kb transcript in the P19CL6 and P19CL6noggin cells using either the 5' (data not shown) or 3' (Figs 5 and 6) probes. Thus, the different expression levels are not due to alternative splicing.
###end p 35
###begin title 36
###xml 23 25 23 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 31 33 27 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 37 38 33 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 38 42 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 38 42 34 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 43 44 39 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 44 48 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 44 48 40 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
Regulation of L-type Ca2+ alpha1c in p100H/p100H mutant mice
###end title 36
###begin p 37
###xml 50 51 50 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 49 51 49 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 56 58 52 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 71 72 67 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 72 76 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 72 76 68 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 77 78 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 78 82 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 78 82 74 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 108 112 104 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 263 264 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c3">3</xref>
###xml 328 329 324 325 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 327 329 323 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 334 336 326 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 359 360 351 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 360 364 352 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 360 364 352 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 365 366 357 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 366 370 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 366 370 358 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 384 385 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f7">7</xref>
###xml 491 493 479 481 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 663 670 651 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 699 703 687 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 777 779 753 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+2</sup>
###xml 785 787 757 759 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 802 803 774 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f7">7</xref>
###xml 836 844 808 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 859 860 831 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f6">6</xref>
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
###xml 606 611 <span type="species:ncbi:10090">mouse</span>
Next, we analyzed the expression of the L-type Ca2+alpha1c gene in the p100H/p100H mutant mouse, which is a Sox6 null mutation that develops significant changes in the ultrastructure of cardiac and skeletal muscle, AV heart block and a cardiac conduction defect (3). RT-PCR was performed to analyze mRNA levels of the L-type Ca2+alpha1c gene in wild type and p100H/p100H hearts (Fig. 7A). Primers were selected to amplify a 548-bp fragment corresponding to nucleotides 6294-6841 of the alpha1c subunit. Total RNA of the samples was calibrated to insure amplification in the linear range. Expression of the mouse GPDH gene was used as an internal control. In this in vivo assay, normal expression of Sox6 is associated with approximately1.5-fold down-regulation of the L-type Ca+2 alpha1c channel (Fig. 7B), which is consistent with our in vitro studies (Fig. 6).
###end p 37
###begin title 38
DISCUSSION
###end title 38
###begin p 39
###xml 441 442 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c2">2</xref>
###xml 612 616 612 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 623 625 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c15">15</xref>
###xml 806 810 806 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 856 858 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c16">16</xref>
###xml 922 926 922 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 503 508 <span type="species:ncbi:4932">yeast</span>
###xml 587 592 <span type="species:ncbi:10090">mouse</span>
Sox proteins distinguish their regulatory targets in a cell type-specific fashion via co-factor binding. They recognize a motif of only 6-7 bp of DNA with considerable degeneracy. However, they appear to regulate different sets of target genes, depending on the cell type in which they are expressed. Cooperative interactions between Sox proteins and their partner factors may allow stable associations with their specific target sequences (2). To identify an interactor of the Sox6 protein we used the yeast two-hybrid system. Screening a cDNA library prepared from an embryonic day-11 mouse, we identified the Prtb gene (15) as an interactor with the Sox6 coiled-coil domain. The interaction was confirmed by Co-IP, demonstrating a physical interaction between the two proteins. Sequence analysis of the Prtb gene indicated a possible 'pair box' domain (16), suggesting that Prtb may function as a transcription factor. Prtb is expressed in embryonic and adult stages in multiple tissues at different levels.
###end p 39
###begin p 40
###xml 24 32 24 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c11">11</xref>
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f3">3</xref>
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f4">4</xref>
###xml 200 204 200 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 274 275 274 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f4">4</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c27">27</xref>
###xml 438 442 438 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 534 538 534 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 621 625 621 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 668 669 668 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 669 673 669 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 669 673 669 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 674 675 674 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 675 679 675 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 675 679 675 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 680 684 <span type="species:ncbi:10090">mice</span>
P19CL6 cells provide an in vitro model for cardiac myocyte differentiation (11). Sox6 is expressed exclusively when these cells are committed to differentiate to cardiac beating cells (Figs 3 and 4). Sox6 is expressed at day 6 following DMSO induction in P19CL6 cells (Fig. 4). A minimum exposure time of 4 days of DMSO is required for differentiation of P19CL6 cells to beating myocytes (27). These findings correlate with the fact that Sox6 is not expressed unless the cells are committed to beating, with the highest expression of Sox6 on day 11, at which point rhythmic contractions begin. The temporal expression of Sox6 in P19CL6 cells (and the mutant phenotype p100H/p100H mice) suggests that Sox6 plays a significant role in cardiogenesis.
###end p 40
###begin p 41
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox5</italic>
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox9</italic>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c28">28</xref>
###xml 357 358 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c8">8</xref>
###xml 529 531 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c29">29</xref>
###xml 575 579 572 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 664 665 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f3">3</xref>
###xml 740 742 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c12">12</xref>
###xml 777 781 774 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox9</italic>
###xml 853 854 850 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f4">4</xref>
###xml 977 981 974 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 986 990 983 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox9</italic>
###xml 1075 1079 1072 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox9</italic>
###xml 1114 1118 1111 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 1151 1153 1148 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c21">21</xref>
###xml 1207 1211 1204 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox9</italic>
###xml 1250 1254 1247 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 1395 1399 1392 1396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 100 106 <span type="species:ncbi:10090">murine</span>
It has been shown that Sox6, together with L-Sox5 and Sox9, undergoes up-regulation by BMP-2 during murine fracture healing (28). On the other hand, it has been shown that Sox6 is an important downstream mediator of BMP-2 signaling in chondrogenesis, whereas other signals control the expression and function of Sox9 as a chondrogenic transcription factor (8). BMPs are members of the transforming growth factor-beta super family and play a crucial role in chondrogenesis as well as in cardiomyocyte differentiation (reviewed in 29). In the present study, we have shown that Sox6 is regulated through the BMP pathway in the differentiation of cardiomyocytes (Fig. 3) using P19CL6 cells stably transfected with noggin, an antagonist of BMP (12). In addition, we have shown that Sox9 expression was high and equal through the DMSO time course assay (Fig. 4). Thus, we suggest that Sox6 is a downstream mediator of BMP signaling in cardiogenesis as well as in chondrogenesis, and Sox6 and Sox9 are probably regulated differently in the cardiac system. Another study showed that Sox9 is required for the expression of Sox6 in chondrocyte differentiation (21). In cardiomycyte differentiation, the expression of Sox9 may be required for the expression of Sox6, but it is clearly not sufficient. Hence, the inducible P19CL6 cells may make it possible to define additional factors that are upstream of Sox6.
###end p 41
###begin p 42
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f3">3</xref>
###xml 355 356 355 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f4">4</xref>
###xml 440 444 440 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
Expression analysis of the Prtb gene in P19CL6 and P19CL6noggin cell lines showed that Prtb is up-regulated when the cells differentiate to beating cardiac cells. Although DMSO, by itself, has a moderate effect on the expression of this gene, its maximum expression is observed 11 days after DMSO treatment when the cardiomyocytes are beating (Figs 3 and 4). Thus, Prtb function might be specified by the cooperation of other genes such as Sox6.
###end p 42
###begin p 43
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c16">16</xref>
###xml 408 409 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c4">4</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c30">30</xref>
###xml 307 318 <span type="species:ncbi:9606">participant</span>
In addition to playing a role in cardiac myocyte development, Prtb and Sox6 may also be involved in bone formation. It has been shown that Prtb is a serum-responsive gene in osteoblasts and is up-regulated during adhesion and possibly involved in processes such as cell cycle control and proliferation as a participant in the extracellular matrix (16). L-Sox5 and Sox6 are essential for cartilage formation (4) and are required for notochord extracellular matrix (30). Thus, it is possible that Sox6 and Prtb cooperate in bone formation.
###end p 43
###begin p 44
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 180 184 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c31">31</xref>
###xml 414 416 410 412 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 483 484 479 480 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 482 484 478 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 637 639 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c13">13</xref>
###xml 750 751 746 747 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 749 751 745 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 757 759 749 751 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 873 874 865 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f5">5</xref>
###xml 1090 1091 1082 1083 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 1089 1091 1081 1083 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 1097 1099 1085 1087 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 1297 1298 1285 1286 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 1296 1298 1284 1286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 1443 1444 1431 1432 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 1442 1444 1430 1432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 1458 1460 1442 1444 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 1547 1549 1531 1533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c32">32</xref>
###xml 1556 1564 1540 1548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1589 1590 1573 1574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f6">6</xref>
###xml 1686 1688 1666 1668 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 1384 1387 <span type="species:ncbi:10116">rat</span>
Elucidation of the target genes of Sox6 and Prtb will be important to understand the process of cardiac myocyte differentiation. The correlation between beating cardiomyocytes and Sox6 expression allows us to evaluate proteins important in contraction as potential targets of Sox6 regulation. For example, cardiac contraction is highly dependent on the gating function of the L-type calcium channel (31). The alpha1c subunit of the calcium channel provides the pore structure for Ca2+ ion entry. It has clinical relevance, since it contains the binding sites for multiple classes of drugs, collectively known as the calcium antagonists (13). To gain insights into the regulation of this channel, we analyzed its expression in P19CL6 cells. L-type Ca2+ alpha1c expression in these cells is dramatically down-regulated following DMSO induction to beating cardiac cells (Fig. 5), opposite the expectation of a direct correlation between beating cells and calcium channel expression. The reduced expression of this gene might result from aberrant regulation by DMSO, as expression of L-type Ca2+ alpha1c was also down-regulated in P19CL6noggin cells treated with DMSO. Another possible explanation for this reduction is that the proliferation of the cells has an impact on expression of the L-type Ca2+ channel. The cells beat when they grow in multilayers. In smooth muscle cells of the rat aorta it was shown that transcription of the L-type Ca2+ channel alpha1c is down-regulated in the proliferative state and it is closely linked to cell growth (32). Our in vitro transfection data (Fig. 6A and B) suggest that the Sox6 or Prtb proteins might at least partially down-regulate the alpha1c channel in the P19CL6 cells treated with DMSO.
###end p 44
###begin p 45
###xml 39 40 39 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 38 40 38 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 46 48 42 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 217 219 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c33">33</xref>
###xml 220 222 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c35">35</xref>
###xml 255 256 251 252 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 254 256 250 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 262 264 254 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 449 450 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c6">6</xref>
###xml 570 572 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c36">36</xref>
###xml 767 768 759 760 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 766 768 758 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 774 776 762 764 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 796 797 784 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f6">6</xref>
###xml 1058 1060 1046 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c37">37</xref>
###xml 1157 1159 1145 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c38">38</xref>
###xml 1332 1334 1314 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c39">39</xref>
###xml 1335 1337 1317 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c40">40</xref>
###xml 1588 1590 1570 1572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c41">41</xref>
###xml 1591 1593 1573 1575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c42">42</xref>
The regulatory region of the L-type Ca2+ alpha1c gene contains eight consensus binding sites for Sox proteins. Multiple Sox binding sites have been reported previously in several other genes regulated by Sox factors (33-35), suggesting that the L-type Ca2+ alpha1c gene might be similarly regulated. Sox6 heterodimerized with Sox5, and in the presence of Sox9, cooperatively activates the expression of col2a (a chondrocyte differentiation marker) (6). On the other hand, Sox6 interacts with CtBP2 (C-terminal binding protein) and causes repression of Fgf-3 expression (36). Thus, Sox6 can function as activator or as a repressor. The transient transfection analysis showed that Sox6 and Prtb (each one by itself) down-regulated the expression level of the L-type Ca2+ alpha1c channel gene (Fig. 6A and B). However, when Sox6 and Prtb are both over-expressed, they appear to antagonize the effects of each. Prtb might antagonize Sox6 repression (or vice versa) by interacting with Sox6 and creating a complex that can no longer interact with its DNA target (37), or a Prtb-associated complex might change the chromatin structure and abrogate Sox6 function (38). It is known that Sox transcription factors bind to the minor groove of DNA causing a 70-85degrees bend of the DNA, consequently introducing local conformational changes (39,40). Therefore, Sox proteins may perform part of their function as architectural proteins by organizing local chromatin structure and assembling other DNA-bound transcription factors into biologically active, sterically defined, multiprotein complexes (41,42).
###end p 45
###begin p 46
###xml 4 5 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 5 9 5 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 5 9 5 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 10 11 10 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 11 15 11 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c3">3</xref>
###xml 206 207 206 207 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 205 207 205 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 213 215 209 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 264 265 248 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 265 269 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 265 269 249 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 270 271 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 271 275 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 271 275 255 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 295 296 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f7">7</xref>
###xml 304 311 288 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 368 369 352 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg807f6">6</xref>
###xml 419 420 403 404 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 418 420 402 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 426 428 406 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 460 462 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c43">43</xref>
###xml 463 465 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg807c44">44</xref>
###xml 672 673 652 653 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 671 673 651 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 679 681 655 657 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 707 711 683 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
###xml 283 288 <span type="species:ncbi:10090">mouse</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
The p100H/p100H mutant mouse is a Sox6 null mutant characterized by early postnatal lethality, associated with progressive atrioventricular heart block and myopathy (3). The cardiac expression of L-type Ca2+ alpha1c is up-regulated by approximately1.5-fold in the p100H/p100H mutant mouse (Fig. 7). This in vivo result correlates with our cell line observations (Fig. 6). Interestingly, knockout mice for the L-type Ca2+ alpha1c die before embryonic day 14.5 (43,44). Deletion of this channel leads to a selective perturbation of cardiac morphogenesis and function in early embryonic development. Further investigation will be required to understand the role of L-type Ca2+ alpha1c in the arrhythmia of the Sox6 mutant homozygote.
###end p 46
###begin p 47
###xml 154 156 150 152 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 182 183 178 179 <bold xmlns:xlink="http://www.w3.org/1999/xlink">+</bold>
###xml 181 183 177 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2<bold>+</bold></sup>
###xml 241 242 237 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 242 246 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 242 246 238 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 247 248 243 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 248 252 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 248 252 244 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
In conclusion, Sox6 is within the BMP pathway in the cardiac system, interacts with Prtb, and may regulate downstream genes in the heart such as the alpha1c-subunit of the L-type Ca2+ channel. The inducible P19CL6 cardiac cell lines and the p100H/p100H mutant mice represent useful models for studying cardiac development, with important implications for understanding congenital heart disease and therapeutic intervention.
###end p 47
###begin title 48
Figures and Tables
###end title 48
###begin p 49
 Protein-protein interaction assay. To verify interactions, we applied the Co-IP technique. The Sox6 bait was tagged with the a c-Myc epitope and each of the two Prtb proteins were tagged with an HA epitope. The first three lanes assay each protein by itself precipitated with an antibody to the corresponding tag. Lanes 4 and 5 assay a mix of two proteins, the Sox6 bait and one of two Prtb proteins (168 or 108 aa, lanes 4 and 5, respectively) allowed to associate prior to precipitation with the HA antibody. The antibody pulled down HA-tagged Prtb proteins and Sox6. Standard marker fragments in kDa are indicated at the left.
###end p 49
###begin p 50
###xml 8 9 8 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 22 23 22 23 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 95 96 91 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 170 172 166 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 195 199 191 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 1 6 <span type="species:ncbi:9606">Human</span>
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
###xml 189 194 <span type="species:ncbi:10090">mouse</span>
 Human (A) and mouse (B) multiple tissue northern blots. Each lane contains 2 microg of poly(A)+ RNA from the tissues indicated above. The filters were hybridized with a 32P-labeled 562 bp mouse Prtb cDNA fragment (nucleotides 15-576). Control hybridization with beta-actin was performed to confirm equal loading of RNAs (data not shown). Abbreviations used: sm. intestine, small intestine; per. blood leuk., peripheral blood leukocyte; sk. muscle, skeletal muscle; colon (mucosal lining). Standard marker fragments in kb are indicated at the left.
###end p 50
###begin p 51
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
 The expression of Sox6 and Prtb in P19CL6 and P19CL6noggin cells, with or without DMSO induction. Each lane contains 10 microg of total RNA from the cells treated as labeled (above). The same filter was serially hybridized with the probes indicated on the right. Hybridization with GPDH is presented to show that the same amount of intact RNA was loaded in each lane. Standard marker fragments in kb are indicated at the left.
###end p 51
###begin p 52
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox9</italic>
 Northern blot analysis of Sox6, Prtb and Sox9 expression in P19CL6 cells treated with DMSO over a time course. Each lane contains 10 microg of total RNA. Numbers above refer to days of DMSO exposure: 0 (before adding DMSO), 2, 4, 6, 8, 10, 11, 12, 14 and 16 days. The cells started to beat on day 11. Hybridization with GPDH is presented to show that the same amount of intact RNA was loaded in each lane.
###end p 52
###begin p 53
###xml 14 16 14 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 30 32 26 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 39 41 31 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 130 132 118 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
 The L-type Ca2+ channel alpha1c (alpha1c) is down-regulated in P19CL6 cells treated with DMSO. The expression levels of the alpha1c subunit were determined by northern blot analysis. Each lane contains 10 microg of total RNA from the cells treated as labeled (above). 18S rRNA is presented to show that the same amount of intact RNA was loaded in each lane.
###end p 53
###begin p 54
###xml 2 3 2 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 40 42 40 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 56 58 52 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 65 67 57 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 125 129 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 134 138 126 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prtb</italic>
###xml 335 336 327 328 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 374 376 362 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 525 526 510 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
 (A) Northern blot analysis of L-type Ca2+ channel alpha1c (alpha1c) expression in P19CL6 cells transiently transfected with Sox6 and Prtb (as described in Materials and Methods). 18S rRNA is presented to show that the same amount of intact RNA was loaded in each lane. This panel shows one of three independent northern experiments. (B) The expression level values of alpha1c, normalized for transfection efficiency by the corresponding beta-Gal value. Three independent transfection experiments were done. Asterisk denotes P </= 0.02 when compared with both control and co-transfection.
###end p 54
###begin p 55
###xml 32 34 32 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 48 50 44 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 57 59 49 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 106 110 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sox6</italic>
###xml 122 123 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 123 127 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 123 127 103 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 128 129 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 129 133 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 129 133 109 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 137 138 117 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 227 228 207 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 228 232 208 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 228 232 208 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 250 251 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 251 255 231 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 251 255 231 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 256 257 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 257 261 237 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">100H</italic>
###xml 257 261 237 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>100H</italic></sup>
###xml 454 455 434 435 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 480 482 460 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 496 498 472 474 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
 The expression of the L-type Ca2+ channel alpha1c (alpha1c) is up- regulated by approximately1.5-fold in Sox6 null mice (p100H/p100H). (A) RT-PCR products amplified from embryonic day 18.5 cardiac tissue of wild-type (WT) and p100H homozygous mice (p100H/p100H). The numbers on the bottom indicate cycle numbers of the PCR. Sizes of the marker standards (M) are: 622, 527 and 404 bp. Amplification of the GPDH fragment was used as an internal control. (B) The amplified L-type Ca2+ channel alpha1c fragment was quantified and normalized with the GPDH fragment using densitometry, and each bar represents the SD of three independent experiments.
###end p 55
###begin title 56
ACKNOWLEDGEMENTS
###end title 56
###begin p 57
We thank our colleagues, Drs Ray Runyan, John Gardner, Ricardo Samson and Drew T. Erickson for their helpful comments on the manuscript. This work was supported by NIH grant GM43840.
###end p 57
###begin title 58
REFERENCES
###end title 58

